Dr. Andreas Pribil graduated in analytical chemistry at the Leopold Franzens University and obtained his doctoral degree in the field of theoretical chemistry in 2009. Soon after he joined Sandoz GmbH as a specialist in analytical development of the biopharma business unit. He worked ther in positions with increasing responsibility including heading a development lab for development and stability analytics of biosimilars. Since 2012 he joined the WBL for applied statistics at the ETH in Zürich. Thereafter in 2013 he joined Novartis as a statistical expert providing expertise on Qbd, SPC and other related tools. On top of that he works as a trainer to provide statistical knowledge.